Top compounds associated with response to SPTLC2


Feature Type Standardized
Nominal ANOVA
mRNA AC220 GDSC1000 pan-cancer AAC 0.068 0.06
mRNA lapatinib FIMM pan-cancer AAC 0.3 0.06
mRNA BHG712 GDSC1000 pan-cancer AAC 0.058 0.07
mRNA Erlotinib gCSI pan-cancer AAC 0.11 0.07
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.064 0.07
mRNA Rapamycin CTRPv2 pan-cancer AAC -0.065 0.07
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.099 0.07
mRNA (5Z)-7-Oxozeaenol GDSC1000 pan-cancer AAC 0.06 0.07
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.064 0.07
mRNA CHM-1 CTRPv2 pan-cancer AAC -0.06 0.07
Download CSV